NAROPIN sol inj 400 mg/200ml polybag 5 pce

7680540151191 CH-54015 N01BB09 01.02.2.

No images available

Details

Product number
5401501
CPT
-
Packaging group
1 x 5 x 200
Unit
ml
Composition
ropivacaini hydrochloridum 2 mg corresp. ropivacainum 1.8 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 3.7 mg.

Articles (1)

Naropin 2 mg/ml, Injektions-/Infusionslösung
Injektions-/Infusionslösung
1 x 5 x 200
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
03/02/2025
Professional SmPC
Français
03/02/2025
Professional SmPC
Italien
03/02/2025

Detailed composition

Substance Quantity Type Category
ropivacaini hydrochloridum
2.0 MG Substance WIZUS
ropivacainum
1.8 MG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
54015
Drug name
Naropin, Injektionslösung
Galenic form
LSIN
ATC Code
N01BB09
Authorization status
Z
Dispensation category
B
First authorization
27/02/1997
Authorization expiration date
31/12/9999
IT number
01.02.2.
Domain
Human medicine
Field of application
Lokalanästhetikum

Packaging details

Description (FR)
NAROPIN sol inj 400 mg/200ml polybag 5 pce
Description (DE)
NAROPIN Inj Lös 400 mg/200ml Polybag 5 Stk
Market launch
27/02/1997
Narcotic (BTM)
No

Other packaging sizes

NAROPIN, sol inj 20 mg/10 ml, Duofit, 5 amp 10 ml
5 x 10 ML
GTIN: 7680540150019
View
NAROPIN 7.5 mg/ml sol perf 5x10 ml
5 x 10 ML
GTIN: 7680540150033
View
Buy us a coffee Explore the data